10-Q: Hillenbrand Reports Q3 Loss Amid Strategic Divestitures
Quarterly Report
Hillenbrand, Inc. reported a net loss for the nine months ended June 30, 2025, despite significant improvements in the latest quarter due to the absence of prior-year impairment charges and pension settlements, as strategic divestitures impacted revenue.
Summary
- Net revenue for the three months ended June 30, 2025, decreased by $187.7 million (24%) to $598.9 million compared to $786.6 million in the prior year.
- For the nine months ended June 30, 2025, net revenue decreased by $323.5 million (14%) to $2,021.7 million from $2,345.2 million in the prior year.
- The Advanced Process Solutions segment's net revenue decreased by 11% for both the three and nine months ended June 30, 2025, primarily due to lower volume.
- The Molding Technology Solutions segment's net revenue decreased by 58% for the three months and 21% for the nine months ended June 30, 2025, largely due to the divestiture of Milacron.
- Consolidated net income attributable to Hillenbrand was $1.9 million for the three months ended June 30, 2025, a significant improvement from a net loss of $248.9 million in the same period last year, primarily due to the absence of $265.0 million in impairment charges and $26.9 million in pension settlement charges from the prior year.
- For the nine months ended June 30, 2025, the net loss attributable to Hillenbrand was $32.6 million, an improvement from a $225.6 million loss in the prior year.
- Adjusted EBITDA from continuing operations decreased by 36% to $84.3 million for the three months and by 24% to $280.1 million for the nine months ended June 30, 2025.
- The company completed the divestiture of its majority interest in the Milacron injection molding and extrusion business on March 31, 2025, receiving $98.0 million in cash and $188.0 million in assumed debt, resulting in a pre-tax loss on divestiture of $56.1 million for the nine months.
- Subsequent to the quarter, Hillenbrand completed the sale of its interest in TerraSource Holdings, LLC on July 1, 2025, for $245.0 million, expecting a pre-tax gain of approximately $66.0 million.
- The company refinanced its credit facilities on July 9, 2025, establishing a new $700 million revolving credit facility, a $175 million U.S. Dollar-denominated term loan, and a €240 million Euro-denominated delayed-draw term loan.
- The $375 million senior unsecured notes due September 2026 were repaid on July 21, 2025, using proceeds from the TerraSource divestiture and the new Euro Term Loans.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While net income improved significantly due to the absence of prior-year one-off charges, underlying revenue and adjusted EBITDA declined. The strategic divestitures and debt refinancing are positive steps for portfolio optimization and financial flexibility, but the immediate operational results show weakness. The company's outlook on liquidity is positive, but external risks remain.
Positives
- Consolidated net income significantly improved for the three and nine months ended June 30, 2025, primarily due to the non-recurrence of large impairment and pension settlement charges from the prior year.
- Interest expense, net, decreased by 34% for the three months and 25% for the nine months ended June 30, 2025, due to lower weighted average borrowings.
- Gross profit margin improved by 50 basis points for the nine months ended June 30, 2025, to 33.3%.
- The Molding Technology Solutions segment's gross profit margin improved significantly by 980 basis points for the three months and 510 basis points for the nine months ended June 30, 2025, driven by productivity improvements and restructuring savings.
- Net cash provided by investing activities from continuing operations increased by $124.6 million for the nine months ended June 30, 2025, largely due to proceeds from the Milacron divestiture.
- The company successfully refinanced its debt facilities and repaid the $375 million senior unsecured notes, enhancing financial flexibility.
- A quarterly dividend increase to $0.2250 per common share was implemented in fiscal 2025, demonstrating commitment to shareholder returns.
- The company maintains a share repurchase program with approximately $125.0 million remaining under authorization.
Negatives
- Net revenue decreased significantly across both reportable segments for the three and nine months ended June 30, 2025, primarily due to lower volume and the Milacron divestiture.
- Adjusted EBITDA from continuing operations decreased by 36% for the three months and 24% for the nine months ended June 30, 2025, indicating a decline in underlying operational profitability.
- Operating activities from continuing operations used $11.5 million in cash for the nine months ended June 30, 2025, compared to providing $24.8 million in the prior year, primarily due to unfavorable timing of working capital requirements.
- The effective tax rate increased significantly to 61.3% for the three months ended June 30, 2025, due to an unfavorable geographic mix of earnings and increased unrecognized tax benefits.
- The company recorded a pre-tax loss of $56.1 million on the divestiture of Milacron for the nine months ended June 30, 2025.
- Selling, general and administrative expenses as a percentage of net revenue increased by 230 basis points for the three months and 270 basis points for the nine months ended June 30, 2025, indicating reduced efficiency relative to revenue.
Risks
- Global market and economic conditions, including volatility in financial markets, U.S. presidential election outcomes, and new tariffs/trade policies.
- Business disruptions associated with information technology, cyber-attacks, or catastrophic losses affecting infrastructure.
- Increasing competition for highly skilled and talented workers, as well as labor shortages and changes in labor costs.
- Uncertainty related to environmental regulation and industry standards, as well as physical risks of climate change.
- Increased costs, poor quality, or unavailability of raw materials or certain outsourced services and supply chain disruptions.
- Economic and financial conditions including volatility in interest and exchange rates, commodity and equity prices, and the value of financial assets.
- Uncertainty in U.S. global trade policy and risks with governmental instability in certain parts of the world, including potential adverse impacts from tariffs and retaliatory measures.
- Negative effects of past acquisitions (Schenck Process Food and Performance Materials, Linxis Group SAS) on business, financial condition, results of operations, and financial performance.
- Competition in the industries of operation, including on price.
- Cyclical demand for industrial capital goods.
- Ability to recognize the benefits of any acquisition or divestiture, including potential synergies and cost savings, or the failure to achieve plans and objectives generally.
- Potential adverse effects of the announcement or results of the Milacron transaction on the market price of common stock or on the ability to maintain relationships with personnel, customers, and suppliers.
- Risks related to diversion of management's attention from ongoing business operations due to the Milacron transaction.
- Impacts of decreases in demand or changes in technological advances, laws, or regulation on net revenues derived from the plastics industry.
- Impact to the effective tax rate of changes in the mix of earnings or in tax laws and certain other tax-related matters.
- Exposure to tax uncertainties and audits.
- Involvement in claims, lawsuits, and governmental proceedings related to operations.
- Uncertainty in the U.S. political and regulatory environment.
- Adverse foreign currency fluctuations.
- Labor disruptions.
Future Outlook
The company expects to further refine the estimated tax expense related to the sale of Milacron throughout the remainder of fiscal 2025. It anticipates a contribution of $11.3 million to its defined benefit pension plans in fiscal 2025, with $5.6 million already made. Quarterly cash dividends are expected to be approximately $15.8 million based on outstanding common stock. The company believes existing cash, cash flows from operations, borrowings under existing arrangements, and debt issuance will be sufficient to fund operating activities and cash commitments, maintaining a sufficient liquidity position.
Management Comments
- We believe the Company ended the quarter with and continues to have sufficient liquidity to operate in the current business environment.
- We continue to assert that the basis differences in the majority of our foreign subsidiaries continue to be permanently reinvested outside of the U.S.
- We have made, and intend to continue to make, substantial investments in our businesses in foreign jurisdictions to support the ongoing development and growth of our international operations.
- We believe existing cash and cash equivalents, cash flows from operations, borrowings under existing arrangements, and the issuance of debt will be sufficient to fund our operating activities and cash commitments for investing and financing activities.
- Based on these factors, we believe our current liquidity position is sufficient and will continue to meet all of our financial commitments in the current business environment.
Industry Context
Hillenbrand operates as a global industrial company providing highly-engineered processing equipment and solutions. Its portfolio serves end markets including durable plastics, food, and recycling. The divestiture of Milacron (plastics) and TerraSource (material handling) indicates a strategic shift towards a more focused portfolio, potentially streamlining operations and reducing exposure to certain cyclical demands within the plastics industry. The company's performance is influenced by global macroeconomic conditions, trade policies, and raw material costs, which are common challenges across industrial sectors.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Interim Chief Financial Officer, Vice President, Corporate Controller and Chief Accounting Officer | NA | Megan A. Walke | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Bylaws Amendment | Amended and Restated Code of By-Laws of Hillenbrand, Inc. became effective. | 2024-04-26 | Updates the company's internal governance framework. |
| Executive Compensation Agreement | Form of Change in Control Agreement entered into by Megan A. Walke. | 2025-06-26 | Provides specific terms for executive compensation in the event of a change in control. |
| Executive Compensation Plan | New Performance-Based Unit Award Agreement (2025 Revision) introduced. | NA | Updates the framework for performance-based stock awards for employees, linking compensation to performance targets over a three-year measurement period. |
Legal Proceedings
- The company is involved in various claims, lawsuits, and government proceedings related to its operations, including environmental, antitrust, patent infringement, business practices, commercial transactions, product and general liability, workers compensation, auto liability, and employment-related matters.
- A discrete commercial dispute, which resulted in $11.2 million in liabilities as of September 30, 2024, was paid during the nine months ended June 30, 2025, and is now at $0.0 million.
Related Party Transactions
- The divestiture of the majority interest in Milacron was completed with an affiliate of Bain Capital, with Hillenbrand retaining a 48.74% minority ownership in the newly formed Milacron Holdings, LLC, which is accounted for under the equity method.
Stakeholder Impact
- Shareholders: Impacted by dividend increase, ongoing share repurchase program, and the strategic divestitures which aim to reshape the company's portfolio, potentially affecting future earnings and stock valuation.
- Employees: Affected by restructuring activities (including severance costs) and changes in share-based compensation plans, which include performance-based awards.
- Customers: Continue to receive highly-engineered processing equipment and solutions, with the company maintaining adequate capacity for bank guarantees and credit arrangements.
- Suppliers: Participation in a supply chain finance program allows qualifying suppliers to sell receivables to financial institutions, potentially impacting their liquidity and payment terms.
- Creditors: Affected by the company's debt refinancing activities, including new term loans and revolving credit facilities, and adherence to leverage ratio covenants.
Next Steps
- Further refinement of estimated tax expense related to the Milacron divestiture throughout the remainder of fiscal 2025.
- Monitoring of plan funding levels, asset performance, and economic activity for defined benefit pension plans, with potential for additional discretionary funding decisions.
- Continued payment of quarterly cash dividends, expected to be approximately $15.8 million.
- Potential utilization of the remaining $125.0 million under the existing share repurchase authorization.
- Integration of new credit facilities and management of associated debt covenants, with leverage ratio targets set through March 31, 2027.
Key Dates
| Date | Description |
|---|---|
| 2023-02-01 | Completion of the divestiture of the Batesville reportable operating segment. |
| 2023-09-25 | Issuance of $375 million senior unsecured notes due September 2026 (2019 Notes). |
| 2023-12-02 | Board of Directors authorized a new share repurchase program of up to $300 million. |
| 2024-04-26 | Effective date of the Amended and Restated Code of By-Laws of Hillenbrand, Inc. |
| 2024-11-19 | Filing of Annual Report on Form 10-K for the year ended September 30, 2024. |
| 2025-03-31 | Completion of the divestiture of majority interest in the Milacron injection molding and extrusion business. |
| 2025-06-26 | Megan A. Walke entered into a Form of Change in Control Agreement. |
| 2025-06-30 | End of the quarterly period covered by this report. |
| 2025-07-01 | Completion of the divestiture of interest in TerraSource Holdings, LLC to Astec Industries. |
| 2025-07-09 | Effective date of the Fifth Amended and Restated Credit Agreement, providing for a new $700 million revolving credit facility, $175 million Dollar Term Loans, and €240 million Euro Term Loans. |
| 2025-07-17 | Completion of an amendment to the Syndicated L/G Facility Agreement, increasing the maximum permitted leverage ratio. |
| 2025-07-21 | Repayment of the $375 million senior unsecured notes due September 2026. |
| 2025-08-01 | Number of common stock shares outstanding was 70,482,047. |
| 2025-08-11 | Date of signing for the Quarterly Report on Form 10-Q. |
Recommendation
holdThe company is undergoing a significant strategic transformation through divestitures (Milacron completed, TerraSource subsequent) and debt refinancing. While the latest quarter shows a substantial improvement in net income due to the absence of prior-year one-off charges, the underlying revenue and adjusted EBITDA performance has declined. The long-term impact of these strategic shifts on profitability and growth is yet to be fully realized. The company's liquidity position appears stable post-refinancing, and it continues to return capital to shareholders through dividends and buybacks. However, the immediate operational headwinds and the ongoing portfolio adjustments suggest a 'hold' stance until there is clearer evidence of sustained operational improvement and the full benefits of the new strategy materialize.
Keywords
Industrial equipment, Processing solutions, Plastics industry, Food processing, Recycling equipment, SEC filing, Quarterly report, Divestiture, Milacron, TerraSource, Financial performance, Revenue decline, EBITDA, Debt refinancing, Shareholder returns, Supply chain, Global trade policy, Risk factors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.